Zimmer Biomet is betting that a portfolio of technologies that support surgeon preferences will help it gain ground in robotics and defend its joint replacement position.
Tariffs were a key topic at OMTEC 2025, with industry leaders stressing the importance of understanding the complexity of the evolving situation to prioritize a response.